The largest database of trusted experimental protocols

Human cytokine xl proteome array

Manufactured by R&D Systems

The Human Cytokine XL Proteome Array is a multiplex assay that allows simultaneous detection and quantification of 105 different human cytokines, chemokines, and other soluble proteins in a single experiment. The array utilizes an optimized panel of carefully selected capture antibodies printed on nitrocellulose-coated glass slides. This technology enables researchers to obtain a comprehensive profile of the complex cytokine network from a small sample volume.

Automatically generated - may contain errors

Lab products found in correlation

4 protocols using human cytokine xl proteome array

1

Cytokine Profiling in THP-1 Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
THP‐1 cells were treated with 10 μM of designated drug or vehicle (DMSO), and 24 h after treatment supernatant was added to Human Cytokine XL proteome array (R&D Systems) in accordance with manufacturer protocol. Chemiluminescence was used to visualize protein quantities. Cytokine analysis from human PBMC's was done on MSD plates as described by manufacturer protocol.
+ Open protocol
+ Expand
2

Cytokine and Angiogenesis Profiling

Check if the same lab product or an alternative is used in the 5 most similar protocols
THP-1 cells were differentiated as previously described in this manuscript. Following differentiation, cells were treated with 10 μM Takinib or DMSO vehicle control. 24 hours after treatment, supernatant was added to Human Cytokine XL proteome array (R&D Systems), or Angiogenesis proteome array. Apoptosis biomarkers were visualized with the Apoptosis Array kit (R&D Systems). All procedures were conducted in accordance with manufacturer protocol. Chemiluminescence was used to visualize protein quantities.
+ Open protocol
+ Expand
3

Cytokine Profiling in THP-1 Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
THP-1 cells were differentiated as previously described and treated with 10 μM designated drug or vehicle (DMSO). Twenty-four hours after treatment, the supernatant was collected and tested in a Human Cytokine XL proteome array (R&D Systems) in accordance with the manufacturer protocol. Cytokine expression was determined by chemiluminescence.
+ Open protocol
+ Expand
4

THP-1 Cytokine Profiling with Takinib

Check if the same lab product or an alternative is used in the 5 most similar protocols
THP-1 Cells were differentiated as previously described in this manuscript. Following differentiation, cells were treated with 10 μM Takinib or DMSO. 24 hours after treatment, supernatant was added to Human Cytokine XL proteome array (R&D Systems). Cytokine kit was conducted in accordance with manufacturer protocol. Chemiluminescence was used to visualize protein quantities.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!